p53 gene aberrations in non-small-cell lung carcinomas from a smoking population
1997

p53 Gene Aberrations in Lung Cancer Among Smokers

Sample size: 46 publication Evidence: moderate

Author Information

Author(s): T Liloglou, H Ross, W Prime, RJ Donnelly, DA Spandidos, JR Gosney, JK Field

Primary Institution: The University of Liverpool

Hypothesis

What is the prevalence and nature of p53 mutations in non-small-cell lung carcinomas among smokers in Merseyside?

Conclusion

p53 mutations in lung cancer patients from Merseyside are less common than in other populations, with a notable prevalence of GC-AT transitions.

Supporting Evidence

  • 28.3% of the tumors had p53 mutations.
  • 67% of samples showed overexpression of the p53 protein.
  • 23.6% of informative cases exhibited loss of heterozygosity at the TP53 locus.
  • p53 mutations were more frequent in squamous cell carcinomas than in adenocarcinomas.
  • Statistical analysis showed no significant correlation between p53 mutations and clinicopathological data.

Takeaway

This study looked at lung cancer samples from smokers and found that changes in a specific gene called p53 are not as common as expected, suggesting other factors might be involved.

Methodology

The study analyzed 46 non-small-cell lung carcinoma samples for p53 mutations, protein expression, and loss of heterozygosity using techniques like SSCP and immunohistochemistry.

Potential Biases

Potential bias due to the predominance of smokers in the sample and the geographic specificity of the study.

Limitations

The study's findings may not be generalizable due to the specific population studied and the low number of non-smokers included.

Participant Demographics

The study included 28 men and 18 women, all Caucasian, with a majority being smokers.

Statistical Information

P-Value

p<0.0002

Statistical Significance

p<0.0002

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication